The slip
PARKINSON RECEIPTno. 8644
24 Oct 2026, 12:36 UTCdopamine neurons, braak
predictionACAD9 in dopamine neurons tracks Braak Lewy-body stage
registered0fb0402f92d5ceb9
discovery-0.12 p=0.767 n=9
replication-0.33 p=0.387 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.12, p 0.767)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT418b4d4b7087e53848548662…
follows 0adfa9eea629…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 8644: ACAD9 in dopamine neurons, braak
- power
- full sample -0.31 (p 0.214, n 18), 95% CI -0.68 to +0.19. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.28 (p 0.254, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.25 (p 0.319, n 18). could be the mix.
- skeptic
- leave-one-out range -0.47 to -0.22, sign flips 0; without severely affected donors -0.31 (p 0.214, n 18). fragile.
- cell type
- strongest in oligodendrocytes: -0.61 (p 0.0075, n 18) vs -0.31 in dopamine neurons. proposing oligodendrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for ACAD9 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up ACAD9 · oligodendrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.38 p 0.183 (needs p < 2.5e-4)